Arrowgrass Capital Partners (US)’s NxStage Medical Inc. NXTM Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-10,000	Closed	-$286K	–	413
2018 Q4	$286K	Buy	+10,000	New	+$284K	0.01%	255
2018 Q3	–	Sell	-67,933	Closed	-$1.9M	–	265
2018 Q2	$1.9M	Buy	+67,933	New	+$1.82M	0.07%	159

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s NXTM Position: Q1 2019 in Review

Arrowgrass Capital Partners (US) sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 10,000 shares — an estimated $286K sold.

Arrowgrass Capital Partners (US) first reported a position in NXTM in Q2 2018 and held it in 2 quarters. The position peaked at $1.9M in Q2 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Arrowgrass Capital Partners (US) reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Arrowgrass Capital Partners (US) sold 10,000 NxStage Medical Inc. shares in Q1 2019, an estimated $286K.
Arrowgrass Capital Partners (US) first reported a position in NxStage Medical Inc. in Q2 2018 and held it in 2 quarters.
Arrowgrass Capital Partners (US)'s NxStage Medical Inc. position peaked at $1.9M in Q2 2018.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q1 2019, filed 15 May 2019.